Medicare Enrolled
Dr. Whitney Chouteau, D.O.
Interventional Pain Medicine Physician · Irving, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chouteau from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chouteau? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chouteau
Dr. Whitney Chouteau is an interventional pain medicine physician in Irving, TX, with 18 years in practice. Based on federal Medicare data, Dr. Chouteau performed 13,014 Medicare services across 1,672 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chouteau received a total of $13,775 from 58 pharmaceutical and/or device companies across 795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chouteau is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 4% volume in TX$ $13,775 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,014
Medicare services
Top 4% in TX for interventional pain medicine physician
1,672
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~723 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 6,845 | $5 | $15 |
| Office visit, established patient (30-39 min) | 1,525 | $89 | $375 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,348 | $109 | $2,229 |
| Drug screening test | 1,337 | $59 | $562 |
| Steroid injection (triamcinolone) | 665 | $1 | $7 |
| Office visit, established patient (20-29 min) | 445 | $68 | $275 |
| New patient office visit (45-59 min) | 107 | $116 | $460 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month | 103 | $39 | $299 |
| Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days | 101 | $40 | $255 |
| Chronic care management, first 20 min/month | 84 | $49 | $272 |
| Joint injection, major joint | 67 | $55 | $813 |
| Office visit, established patient (10-19 min) | 56 | $34 | $175 |
| Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month | 39 | $31 | $290 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 38 | $112 | $4,192 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 36 | $185 | $3,538 |
| Injection of trigger points, 3 or more muscles | 31 | $42 | $357 |
| Injection of substance into lower spine canal using imaging guidance | 22 | $198 | $3,565 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 21 | $185 | $4,872 |
| Injection of trigger points, 1-2 muscles | 20 | $36 | $375 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 20 | $95 | $2,755 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 20 | $242 | $2,484 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 19 | $451 | $7,834 |
| Set-up and patient education for remote monitoring of therapy | 19 | $15 | $269 |
| Chronic care management, additional 20 min/month | 18 | $37 | $247 |
| Injection of substance into middle or upper spine canal using imaging guidance | 17 | $82 | $4,294 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 11 | $71 | $1,930 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,775
Total received (2018-2024)
Avg $1,968/year across 7 years
Top 27% in TX for interventional pain medicine physician
58
Companies
795
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,642 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$133 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,030
2023$2,266
2022$2,275
2021$1,856
2020$957
2019$1,698
2018$1,693
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$2,288
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,186
Medtronic USA, Inc.
$961
Forte Bio-Pharma LLC
$826
ABBVIE INC.
$755
PFIZER INC.
$724
SPR Therapeutics, Inc
$628
Medtronic, Inc.
$626
Abbott Laboratories
$458
AbbVie Inc.
$451
Nevro Corp.
$371
Allergan, Inc.
$361
Scilex Pharmaceuticals Inc.
$308
SCILEX PHARMACEUTICALS INC.
$260
Allergan Inc.
$214
IBSA Pharma Inc.
$207
Lilly USA, LLC
$198
Merck Sharp & Dohme LLC
$190
FORTE BIO-PHARMA LLC
$180
BOSTON SCIENTIFIC CORPORATION
$159
Almatica Pharma LLC
$144
Zynex Medical, Inc.
$138
Daiichi Sankyo Inc.
$136
BioDelivery Sciences International, Inc.
$135
RedHill Biopharma Inc.
$118
Horizon Therapeutics plc
$117
Pacira Therapeutics, Inc.
$111
Azurity Pharmaceuticals, Inc.
$109
Vertos Medical, Inc.
$105
Hikma Pharmaceuticals USA
$97
Takeda Pharmaceuticals U.S.A., Inc.
$85
Valinor Pharma, LLC
$74
GRT US Holding, Inc.
$74
Bioventus LLC
$73
Lundbeck LLC
$71
Arbor Pharmaceuticals, Inc.
$68
Biohaven Pharmaceutical Holding Company Ltd.
$67
ARBOR PHARMACEUTICALS, INC.
$65
Radius Health, Inc.
$64
Fidia Pharma USA Inc.
$54
Brainsway USA INC
$54
Boston Scientific Corporation
$52
Pacira Pharmaceuticals Incorporated
$51
Baudax Bio Inc.
$48
Purdue Pharma L.P.
$40
SI-BONE, INC.
$32
Kowa Pharmaceuticals America, Inc.
$31
USWM, LLC
$29
Pernix Therapeutics Holdings, Inc.
$26
Averitas Pharma Inc.
$26
Horizon Pharma plc
$26
DePuy Synthes Sales Inc.
$22
Biohaven Pharmaceuticals, Inc.
$19
Shionogi Inc
$16
Egalet US Inc
$16
Flexion Therapeutics, Inc.
$13
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$11
Amgen Inc.
$11
Top 3 companies account for 32.2% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ANJESO · ARYMO ER · ASCENDA · Amitiza · BELBUCA · BELSOMRA · BOTOX · BOTOX - SPASTICITY · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Belbuca · Brainsway Deep TMS · DUEXIS · DUROLANE · Durolane · EMGALITY · ETERNA · EXPAREL · Edarbyclor · Entyvio · Exparel · FLECTOR · FORTEO · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GRALISE · HORIZANT · HYMOVIS · Horizant · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LICART · LYRICA · Licart · Lucemyra · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NALOCET · NAPRELAN · NURTEC ODT · Nalocet · Nexwave · OCTRODE · Omnia · PAXLOVID · PENNSAID · PROCLAIM · PROLATE · Proclaim Family of SCS IPGs · Proclaim IPG · Prolia · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · SCS IPGs · SEGLENTIS · SPECTRA WAVEWRITER · SPRINT PNS System · SYMPHION · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Seglentis · Senza · Symproic · Tirosint · Tymlos · UBRELVY · VIMOVO · VYEPTI · XTAMPZA · XTAMPZAER · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $106 per 100 Medicare services performed
Geographic Context
Interventional Pain Medicine Physicians within 10 mi
35
Per 100K population
1.3
County median income
$74,149
Nearest hospital
MEDICAL CITY LAS COLINAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chouteau is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chouteau experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Chouteau performed 6,845 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chouteau receive payments from pharmaceutical companies?
Yes. Dr. Chouteau received a total of $13,775 from 58 companies across 795 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chouteau's costs compare to other interventional pain medicine physicians in Irving?
Dr. Chouteau's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chouteau) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Irving
Browse interventional pain medicine physicians in Irving ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in TX
Interventional Pain Medicine Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in TX
Which TX interventional pain medicine physicians receive the most from drug and device companies.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc..
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology